Đăng xuất
Prophylaxis of tetanus in wound management
Adult: Consider the immunisation status of the patient and the type and condition of the wound. Non-immunised or partially immunised patients, uncertain vaccination history; completely immunised and >10 years since last booster dose: 0.5 mL (≥40 IU) to be given immediately. Completely immunised patients with minor, clean wounds who have been vaccinated within the last 5-10 years may not need a prophylaxis dose. Non-immunised or partially immunised patients or those with uncertain vaccination history are recommended to start and complete a primary series. Refer to detailed product or local treatment guidelines for specific dosing recommendations.
Intramuscular
Active immunisation against tetanus
Adult: As ≥40 IU/0.5 mL preparation: Primary immunisation: 0.5 mL for 2 doses, given 4-8 weeks apart, followed by a 3rd dose of 0.5 mL 6-12 months after the 2nd dose. Booster dose: 0.5 mL every 10 years. For neonatal tetanus prophylaxis in pregnant women, the 1st dose is preferably administered ≥90 days prior to birth.
Child: Neonates, infants, children, and adolescents Primary immunisation: Same as adult dose. Treatment recommendations may vary per country; refer to local product guidelines and paediatric vaccine schedules for specific recommendations.
Child: Neonates, infants, children, and adolescents Primary immunisation: Same as adult dose. Treatment recommendations may vary per country; refer to local product guidelines and paediatric vaccine schedules for specific recommendations.
